Switching From Intravenous to Subcutaneous Infliximab in Adult Patients With Inflammatory Bowel Disease
NCT06381518
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
IBD
Infliximab
Crohn Disease
Ulcerative Colitis
Interventions
OTHER:
Switch to SC CT-P13.
Sponsor
Zuyderland Medisch Centrum